Top Markets
Coin of the day
Gilead Sciences, Inc. Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILD
Classifica tra le azioni #93
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and... Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Prezzo delle azioni
$137.21
Capitalizzazione di mercato
$170.34B
Variazione (1 giorno)
-2.76%
Variazione (1 anno)
28.14%
Paese
US
Scambia Gilead Sciences, Inc. (GILD)

Categoria

Storico del prezzo dell'azione per Gilead Sciences, Inc. (GILD)
Prezzo di chiusura più alto: $145.05 il 2026-03-01

Prezzo di chiusura più basso: $0.68 il 1992-01-01
Storico del prezzo dell'azione di Gilead Sciences, Inc. dal 1992 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -2.54%
2025 32.61%
2024 15.91%
2023 -8.13%
2022 21.80%
2021 20.36%
2020 -10.67%
2019 1.05%
2018 -11.26%
2017 0.81%
2016 -28.48%
2015 2.18%
2014 36.94%
2013 97.78%
2012 89.44%
2011 6.01%
2010 -17.54%
2009 -5.59%
2008 2.32%
2007 41.69%
2006 23.58%
2005 49.12%
2004 22.34%
2003 58.83%
2002 9.38%
2001 62.12%
2000 85.71%
1999 27.06%
1998 -1.72%
1997 35.42%
1996 -4.72%
1995 201.95%
1994 -24.84%
1993 -22.36%
1992 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$906.59 8.24%
US
$183.60 145.03%
GB
$235.37 43.84%
US
$205.07 -2.35%
US
$146.03 30.23%
CH